SCHEMBL27429899

SCHEMBL27429899

CN(C(=N)Nc1cccc(C(F)(F)F)c1)c1cc(C(F)(F)F)sc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
TP53 P04637 1/20 0.47
GAA P10253 3/20 0.45
LMNA P02545 2/20 0.44
MAPT P10636 7/20 0.43
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
HTT P42858 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 4/20 0.42
TDP1 Q9NUW8 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27545203 0.86 MEN1 (0.47) MEN1KMT2ATP53GAALMNA
SCHEMBL6720918 0.79 MEN1 (0.51) MEN1KMT2ATP53GAALMNA
SCHEMBL27453440 0.79 KDR (0.49) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL6727687 0.78 SIGMAR1 (0.51) MEN1KMT2ATP53GAALMNA
SCHEMBL27424513 0.77 HSD17B1 (0.40) MEN1KMT2ATP53GAALMNA
SCHEMBL6720634 0.76 MEN1 (0.51) MEN1KMT2ATP53GAALMNA
SCHEMBL6727685 0.76 ALDH1A1 (0.46) MEN1KMT2ATP53GAALMNA
SCHEMBL6728001 0.75 ALDH1A1 (0.43) MEN1KMT2ATP53GAALMNA
SCHEMBL6719746 0.75 ALDH1A1 (0.45) MEN1KMT2ATP53GAALMNA
SCHEMBL6724367 0.74 MEN1 (0.49) MEN1KMT2ATP53GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1126434-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE INC (US) 1996-07-10 CN claimed
CN-1126434-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE INC (US) 1996-07-10 CN disclosed